NCT07006467View on ClinicalTrials.gov

Initial Feasibility Study of the STENTiT Resorbable Fibrillated Scaffold (RFS). The RFS is Intended to Restore Lumen Patency and Blood Flow to Infrapopliteal Arteries. The RFS is a Fully Electrospun Tubular Device With a Fibrillated Microarchitecture and Designed for Transcatheter Delivery

NARecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

June 3, 2025

Primary Completion Date

September 30, 2025

Study Completion Date

August 31, 2027

Conditions

Critical Limb Ischemia (CLI)

Interventions

DEVICE

Implantation of RFS

Percutaneous transluminal implantation of the RFS in the infrapopliteal lesion

Trial Locations (1)

A-8036

RECRUITING

Medical Universiteit Graz, Graz

All Listed Sponsors

lead

Stentit

INDUSTRY

NCT07006467 - Initial Feasibility Study of the STENTiT Resorbable Fibrillated Scaffold (RFS). The RFS is Intended to Restore Lumen Patency and Blood Flow to Infrapopliteal Arteries. The RFS is a Fully Electrospun Tubular Device With a Fibrillated Microarchitecture and Designed for Transcatheter Delivery | Biotech Hunter | Biotech Hunter